GO:0090554 phosphatidylcholine floppase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090554 phosphatidylcholine floppase activity describes ATP-dependent movement of phosphatidylcholine from the cytosolic to the exoplasmic leaflet of a membrane.
• ABCB4 (MDR3) is the best-characterized mammalian phosphatidylcholine floppase, and its activity is essential for biliary phosphatidylcholine secretion and liver health.
• Missense mutations in ABCB4 that impair floppase activity cause progressive familial intrahepatic cholestasis type 3 and other cholestatic liver diseases.
• The catalytic cycle of ABCB4 is proposed to follow a credit-card-swipe mechanism, where phosphatidylcholine is extracted from the cytosolic leaflet and extruded into the exoplasmic leaflet.
• Phosphatidylcholine floppase activity maintains transverse lipid asymmetry of the plasma membrane, which is critical for cell signaling, vesicle trafficking, and membrane integrity.
• Studying GO:0090554 requires assays such as fluorescent phosphatidylcholine floppase assays, cell-based scrambling assays, and CRISPR-engineered cell models.
Description
Phosphatidylcholine floppase activity (GO:0090554) is a molecular function that catalyzes the ATP-dependent translocation of phosphatidylcholine from the cytosolic leaflet to the exoplasmic leaflet of a membrane. This activity is a specialized form of lipid flopping that contributes to the asymmetric distribution of phospholipids across biological membranes, a hallmark of eukaryotic cells. The reaction consumes ATP and is distinct from scramblases, which move lipids bidirectionally down their concentration gradient. Among the proteins that exhibit this activity, the ATP-binding cassette transporter ABCB4 (also known as MDR3) is the most extensively studied in mammals. ABCB4 floppase activity is required for the secretion of phosphatidylcholine into bile, where it protects cholangiocytes and hepatocytes from the detergent effects of bile salts. Loss-of-function mutations in ABCB4 lead to progressive familial intrahepatic cholestasis type 3 (PFIC3) and related cholestatic disorders, underscoring the physiological importance of this activity. For researchers, GO:0090554 provides a precise functional annotation for genes and proteins involved in lipid transport, membrane asymmetry, and liver disease. Understanding its mechanism, regulation, and disease relevance is essential for developing targeted therapies and for interpreting genetic variants of uncertain significance in ABCB4 and related transporters.
phosphatidylcholine floppase activity At A Glance
| GO ID | GO:0090554 |
|---|---|
| GO term | phosphatidylcholine floppase activity |
| Ontology | molecular_function |
| Synonym | ATPase-coupled phosphatidylcholine transporter activity; ATP-dependent phosphatidylcholine transporter activity; phosphatidylcholine floppase activity (cytosolic to exoplasmic leaflet); phosphatidylcholine-translocating ATPase activity |
| Definition | Catalysis of the movement of phosphatidylcholine from the cytosolic to the exoplasmic leaflet of a membrane, using energy from the hydrolysis of ATP. |
| Major function | ATP-dependent translocation of phosphatidylcholine across membrane bilayers to maintain lipid asymmetry. |
| Representative protein | ABCB4 (MDR3) in humans; MRP1 (ABCC1) also exhibits floppase activity in reconstituted systems. |
| Associated disease | Progressive familial intrahepatic cholestasis type 3 (PFIC3) and other ABCB4-related cholestatic liver diseases. |
| Research methods | Fluorescent phosphatidylcholine floppase assays, cell-based scrambling assays, CRISPR knockout/knock-in models. |
What Is GO:0090554?
Phosphatidylcholine floppase activity is defined as the catalysis of phosphatidylcholine movement from the cytosolic to the exoplasmic leaflet of a membrane, using energy derived from ATP hydrolysis. This activity is also known as ATPase-coupled phosphatidylcholine transporter activity or ATP-dependent phosphatidylcholine transporter activity. It is a molecular function that establishes and maintains the asymmetric distribution of phosphatidylcholine across membrane bilayers.
Why Is phosphatidylcholine floppase activity Important in Cell Biology?
Phosphatidylcholine floppase activity is critical for maintaining the transverse lipid asymmetry of cell membranes, a fundamental feature that influences membrane curvature, vesicle budding, and signal transduction. In the liver, ABCB4-mediated floppase activity is indispensable for biliary phosphatidylcholine secretion, which protects against bile salt-induced membrane damage. Dysregulation of this activity is directly linked to cholestatic liver diseases, and genetic variants that impair floppase function are increasingly recognized as contributors to drug-induced liver injury and gallstone formation. Thus, GO:0090554 is a key annotation for understanding membrane biology and for developing diagnostics and therapeutics targeting lipid transport.
• Maintains phosphatidylcholine asymmetry between the cytosolic and exoplasmic leaflets of the plasma membrane.
• Enables biliary phosphatidylcholine secretion, which neutralizes bile salt toxicity in the liver.
• Mutations in ABCB4 that reduce floppase activity cause PFIC3 and related cholestatic disorders.
• Contributes to the mechanism of multidrug resistance-associated protein MRP1 (ABCC1) in reconstituted systems.
• Distinguishes ATP-dependent floppases from ATP-independent scramblases such as TMEM16F.
• Provides a functional readout for classifying ABCB4 variants of uncertain significance in clinical genetics.
• Influences membrane trafficking, cell signaling, and apoptosis through lipid asymmetry.
• Serves as a target for pharmacological modulation of lipid transport in liver disease.
• Supports the development of cell-based assays for drug screening and mechanistic studies.
• Links lipid metabolism to inherited and acquired cholestatic liver diseases.
What Happens During phosphatidylcholine floppase activity?
Substrate recognition and binding
In simple terms: The floppase first grabs a phosphatidylcholine molecule from the inner side of the membrane.
Phosphatidylcholine floppases such as ABCB4 recognize and bind phosphatidylcholine within the cytosolic leaflet of the membrane. Structural and biochemical studies suggest that the substrate enters a hydrophobic cavity formed by the transmembrane domains of the transporter. The binding step is selective for phosphatidylcholine over other phospholipids, as demonstrated by cell-based scrambling assays that reveal headgroup preference. This initial recognition is essential for the subsequent ATP-dependent translocation.
ATP hydrolysis and conformational change
In simple terms: The protein uses ATP as an energy source to change its shape and push the lipid across.
ATP binding and hydrolysis by the nucleotide-binding domains of ABCB4 drive conformational changes that propel phosphatidylcholine across the membrane. The catalytic cycle is coupled to the floppase activity, as evidenced by the requirement for ATP in fluorescent phosphatidylcholine floppase assays. Mutations in the ATP-binding regions of ABCB4 impair this step and reduce floppase activity.
Lipid translocation across the bilayer
In simple terms: The lipid is flipped from the inner leaflet to the outer leaflet of the membrane.
Following ATP hydrolysis, phosphatidylcholine is translocated from the cytosolic to the exoplasmic leaflet. This movement is unidirectional and against the concentration gradient, distinguishing floppases from scramblases. The credit-card-swipe mechanism has been proposed for ABCB4, in which the lipid is extracted from the cytosolic leaflet and inserted into the exoplasmic leaflet through a lateral opening in the transporter.
Release and membrane asymmetry maintenance
In simple terms: After the lipid is flipped, it stays on the outer side, helping keep the two sides of the membrane different.
Once phosphatidylcholine is delivered to the exoplasmic leaflet, it is released from the transporter, and the protein returns to its resting state. The continuous action of floppases, together with flippases and scramblases, maintains the asymmetric distribution of phospholipids across the membrane. In the liver, this asymmetry is critical for the formation of phosphatidylcholine-rich bile and for protecting cell membranes from bile salt toxicity.
Key Genes Involved in GO:0090554 phosphatidylcholine floppase activity
The following genes and proteins are directly implicated in phosphatidylcholine floppase activity (GO:0090554) or in its regulation and physiological context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ABCB4 (MDR3) | Primary phosphatidylcholine floppase in hepatocytes; translocates PC into bile | Mutations cause PFIC3 and cholestatic liver disease; target for functional studies |
| ABCC1 (MRP1) | Multidrug resistance-associated protein with reconstituted PC floppase activity | Model for studying ATP-dependent PC transport in vitro |
| TMEM16F (ANO6) | Calcium-activated scramblase with headgroup preference; not a floppase but relevant to lipid asymmetry | Used as a comparator in cell-based scrambling assays |
| ATP8B1 (FIC1) | Aminophospholipid flippase; maintains membrane asymmetry in liver | Mutations cause PFIC1; interacts with ABCB4 function |
| ABCG5/ABCG8 | Sterol transporters; not PC floppases but contribute to biliary lipid secretion | Studied in gallstone disease and lipid homeostasis |
| SLC4A2 (AE2) | Anion exchanger; regulates biliary pH and indirectly affects PC secretion | Potential modifier of ABCB4-related cholestasis |
| NR1H4 (FXR) | Nuclear receptor regulating bile acid and lipid transporters including ABCB4 | Therapeutic target for cholestatic liver disease |
| ABCB11 (BSEP) | Bile salt export pump; functional partner of ABCB4 in bile formation | Mutations cause PFIC2; used in co-expression studies |
| ATP11A | P4-ATPase flippase; maintains PC and PS asymmetry | Model for studying opposing lipid transport activities |
| ATP11C | P4-ATPase flippase; regulates phosphatidylserine exposure | Relevant to membrane asymmetry and cell signaling |
| XKR8 | Scramblase activated during apoptosis; exposes phosphatidylserine | Contrasts with floppase function in membrane dynamics |
| PLSCR1 | Phospholipid scramblase; bidirectional lipid movement | Studied for its role in lipid asymmetry loss |
| ABCA1 | Cholesterol and phospholipid transporter; affects membrane lipid composition | Indirectly influences PC floppase substrate availability |
| ABCG1 | Cholesterol efflux transporter; modulates membrane lipid domains | Potential crosstalk with PC floppase activity |
| SCARB1 (SR-BI) | HDL receptor; influences plasma membrane lipid distribution | Model for studying lipid asymmetry in hepatocytes |
| CYP7A1 | Rate-limiting enzyme in bile acid synthesis; affects bile composition | Indirect regulator of ABCB4 expression and PC secretion |
| TJP2 (ZO-2) | Tight junction protein; mutations cause cholestasis | Potential modifier of ABCB4-related disease |
| BAAT | Bile acid-CoA:amino acid N-acyltransferase; bile acid conjugation | Affects bile salt toxicity and PC requirement |
How Is phosphatidylcholine floppase activity Regulated?
Phosphatidylcholine floppase activity is regulated at multiple levels. Transcriptional regulation of ABCB4 is controlled by bile acid-activated nuclear receptors such as FXR (NR1H4), which induces ABCB4 expression in response to increased bile acid levels. Post-translational modifications, including phosphorylation and glycosylation, can modulate ABCB4 trafficking and activity. Additionally, the lipid composition of the membrane itself influences floppase efficiency, as the availability of phosphatidylcholine substrate and membrane fluidity affect the catalytic cycle. Mutations in ABCB4 that alter protein stability or ATPase activity directly impact floppase function and are associated with variable clinical phenotypes.
phosphatidylcholine floppase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ABCB4 | PFIC3; cholestatic liver disease; impaired biliary PC secretion | Hepatocyte-like cells with ABCB4 knockout or point mutations (e.g., S320F) |
| ABCB4 | Variants of uncertain significance predisposing to secondary pathologies | Knock-in cell lines expressing D243A, K435T, G535D, I490T, R545C, or S978P |
| ABCC1 | Multidrug resistance; reconstituted PC floppase activity | In vitro reconstituted proteoliposome assay with purified MRP1 |
| TMEM16F | Scott syndrome; calcium-dependent scrambling | Cell-based scrambling assay with TMEM16F overexpression or knockout |
| ATP8B1 | PFIC1; membrane asymmetry defects | CRISPR knockout of ATP8B1 in hepatic cell lines |
Progressive familial intrahepatic cholestasis type 3 (PFIC3)
PFIC3 is an autosomal recessive liver disease caused by mutations in ABCB4 that impair phosphatidylcholine floppase activity. Reduced floppase activity leads to decreased biliary phosphatidylcholine, resulting in bile salt-induced damage to cholangiocytes and hepatocytes. Functional analysis of ABCB4 mutations has shown that the degree of residual floppase activity correlates with clinical outcomes, with severe mutations causing early-onset cholestasis and liver failure. The S320F variant, for example, exhibits defective floppase activity and is associated with a spectrum of cholestatic disease.
ABCB4-related cholestatic liver disease and variant classification
Beyond PFIC3, missense mutations such as D243A, K435T, G535D, I490T, R545C, and S978P in ABCB4 significantly impair lipid floppase activity and likely predispose to secondary pathologies in the human population. These variants are often classified as variants of uncertain significance in clinical genetics, and functional assays of floppase activity are critical for reclassification. The credit-card-swipe mechanism provides a structural framework for understanding how these mutations disrupt substrate translocation.
Membrane asymmetry and broader disease relevance
Loss of phosphatidylcholine floppase activity contributes to disruption of transverse lipid asymmetry, which is linked to altered cell signaling, vesicle trafficking, and apoptosis. While the most direct disease association is with cholestatic liver disease, the broader role of floppases in maintaining membrane integrity suggests potential involvement in other pathologies, including drug-induced liver injury and gallstone formation. The cell-based scrambling assay for TMEM16F highlights how headgroup preference and lipid movement can be studied in disease contexts.
From phosphatidylcholine floppase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ABCB4 abolish phosphatidylcholine floppase activity? | ABCB4 knockout hepatocyte cell line (e.g., HepG2 or primary hepatocytes) |
| How does the S320F mutation affect floppase function? | Point-mutation knock-in of S320F in ABCB4-expressing cells |
| Can a specific ABCB4 variant be reclassified as pathogenic? | Knock-in of patient variants (e.g., D243A, K435T) followed by fluorescent floppase assay |
| Where is ABCB4 localized during floppase activity? | Tagged knock-in of ABCB4 with fluorescent protein for live-cell imaging |
| Does overexpression of ABCB4 increase PC floppase activity? | Overexpression of wild-type ABCB4 in polarized epithelial cells |
| What is the headgroup preference of a candidate floppase? | Cell-based scrambling assay with fluorescent lipid analogs |
How to Study the phosphatidylcholine floppase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent PC floppase assay | ATP-dependent translocation of fluorescent PC across membranes | Quantifying activity of purified MRP1 or ABCB4 |
| Cell-based scrambling assay | Headgroup preference and lipid movement on plasma membrane | Comparing floppase vs scramblase activity |
| CRISPR knockout screen | Genes required for PC floppase activity or membrane asymmetry | Identifying modifiers of ABCB4 function |
| Site-directed mutagenesis | Effect of specific ABCB4 mutations on floppase activity | Functional classification of clinical variants |
| Live-cell imaging | Subcellular localization and dynamics of tagged ABCB4 | Studying trafficking and membrane insertion |
| ATPase assay | ATP hydrolysis coupled to lipid transport | Confirming energy coupling of floppase |
| Lipidomics | Phosphatidylcholine distribution in membrane leaflets | Assessing membrane asymmetry changes |
| Reconstituted proteoliposome assay | Direct floppase activity of purified protein | Mechanistic studies of MRP1 and ABCB4 |
Fluorescent phosphatidylcholine floppase assay
This assay uses fluorescently labeled phosphatidylcholine analogs to measure ATP-dependent translocation across membrane vesicles or reconstituted proteoliposomes. It is the gold-standard method for directly quantifying floppase activity of purified proteins such as MRP1 or ABCB4. The assay can be adapted for high-throughput screening of mutations or small-molecule modulators.
Cell-based scrambling assay
A cell-based scrambling assay using fluorescent lipid analogs reveals the phospholipid headgroup preference of scramblases and floppases on the plasma membrane. This method is particularly useful for distinguishing between ATP-dependent floppase activity and calcium-dependent scramblase activity. It can be applied to cells expressing wild-type or mutant transporters.
CRISPR-based genetic screens
CRISPR knockout or activation screens can identify genes that regulate phosphatidylcholine floppase activity or compensate for its loss. Libraries targeting lipid transporters, kinases, and transcription factors can be screened using fluorescent lipid uptake or efflux readouts. Hits can be validated by targeted knockout and functional assays.
Structural and biochemical approaches
Cryo-electron microscopy and homology modeling have provided insights into the credit-card-swipe mechanism of ABCB4. Biochemical assays measuring ATPase activity in the presence of phosphatidylcholine can confirm coupling of ATP hydrolysis to lipid translocation. Mutational analysis of the substrate-binding cavity helps map residues critical for floppase function.
How CRISPR Can Be Used to Study GO:0090554 phosphatidylcholine floppase activity
Knockout
CRISPR knockout of ABCB4 in hepatocyte cell lines abolishes phosphatidylcholine floppase activity, providing a clean background to study the consequences of loss of function. Knockout models can be used to measure changes in biliary PC secretion, membrane asymmetry, and susceptibility to bile salt toxicity. These models are also valuable for validating candidate genes identified in screens.
Point Mutation
CRISPR-mediated point mutation knock-in allows the introduction of specific clinical variants such as S320F, D243A, or K435T into the endogenous ABCB4 locus. These models recapitulate the functional impact of patient mutations on floppase activity and can be used to correlate genotype with phenotype. They are essential for reclassifying variants of uncertain significance.
Knock-in
Tagged knock-in of ABCB4 with fluorescent or epitope tags enables real-time tracking of the floppase in live cells. Knock-in of reporter genes under the ABCB4 promoter can be used to study transcriptional regulation by FXR and other factors. These models facilitate imaging and proteomic studies of the floppase complex.
Overexpression
Overexpression of wild-type or mutant ABCB4 in polarized epithelial cells increases phosphatidylcholine floppase activity and can be used to study substrate specificity and transport kinetics. Overexpression models are also useful for producing protein for structural studies. They can be combined with fluorescent lipid assays to measure activity in intact cells.
How EDITGENE Supports phosphatidylcholine floppase activity Research
Researchers studying phosphatidylcholine floppase activity-related genes often need to determine whether a candidate gene is causally involved in lipid transport, membrane asymmetry, or cholestatic disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for functional validation of GO:0090554-associated genes.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylcholine floppase activity research.
Frequently Asked Questions About phosphatidylcholine floppase activity
What is phosphatidylcholine floppase activity?
Phosphatidylcholine floppase activity (GO:0090554) is the ATP-dependent movement of phosphatidylcholine from the cytosolic to the exoplasmic leaflet of a membrane, catalyzed by proteins such as ABCB4.
What genes are involved in phosphatidylcholine floppase activity?
The major gene is ABCB4 (MDR3), which encodes a phosphatidylcholine floppase in hepatocytes. ABCC1 (MRP1) also exhibits this activity in reconstituted systems.
What is the role of ABCB4 in phosphatidylcholine floppase activity?
ABCB4 translocates phosphatidylcholine across the canalicular membrane into bile, protecting cholangiocytes from bile salt toxicity.
How is phosphatidylcholine floppase activity measured?
It is measured using fluorescent phosphatidylcholine floppase assays, cell-based scrambling assays, and ATPase assays with purified protein or reconstituted proteoliposomes.
What diseases are associated with impaired phosphatidylcholine floppase activity?
Mutations in ABCB4 that reduce floppase activity cause progressive familial intrahepatic cholestasis type 3 (PFIC3) and other cholestatic liver diseases.
What is the difference between a floppase and a scramblase?
Floppases use ATP to move specific lipids unidirectionally from the cytosolic to the exoplasmic leaflet, while scramblases facilitate bidirectional, ATP-independent lipid movement.
How does the S320F mutation in ABCB4 affect floppase activity?
The S320F variant impairs phosphatidylcholine floppase activity and is associated with a spectrum of cholestatic disease.
Can CRISPR be used to study phosphatidylcholine floppase activity?
Yes, CRISPR knockout, point mutation knock-in, and overexpression models are widely used to study the function of ABCB4 and other floppases.
What is the credit-card-swipe mechanism in ABCB4?
It is a proposed model in which ABCB4 extracts phosphatidylcholine from the cytosolic leaflet and inserts it into the exoplasmic leaflet through a lateral opening, similar to a credit card being swiped.
Why is phosphatidylcholine floppase activity important for liver health?
It ensures adequate phosphatidylcholine in bile, which neutralizes bile salts and prevents cholestatic liver damage.
Conclusion
Phosphatidylcholine floppase activity (GO:0090554) is a fundamental molecular function that maintains membrane lipid asymmetry and supports critical physiological processes, particularly biliary phosphatidylcholine secretion in the liver. The ABCB4 transporter is the prototypical mammalian floppase, and its dysfunction is directly linked to PFIC3 and other cholestatic diseases. Advances in structural biology and CRISPR-based models continue to elucidate the catalytic mechanism and disease relevance of this activity. For researchers, targeting GO:0090554 with precise genetic tools offers a powerful approach to dissect lipid transport mechanisms and to develop therapeutic strategies for liver disease. EDITGENE's CRISPR services provide the necessary models to accelerate this research.
References
- 1. Huang Z et al.. 2004. Fluorescent modified phosphatidylcholine floppase activity of reconstituted multidrug resistance-associated protein MRP1.. Biochim Biophys Acta 1660(1-2):155-63 PMID: 14757231
- 2. Linton KJ. 2015. Lipid flopping in the liver.. Biochem Soc Trans 43(5):1003-10 PMID: 26517915
- 3. Gordo-Gilart R et al.. 2015. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.. Gut 64(1):147-55 PMID: 24594635
- 4. Andress EJ et al.. 2014. Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4.. Hepatology 59(5):1921-31 PMID: 24806754
- 5. Teo CF et al.. 2025. A cell-based scrambling assay reveals the phospholipid headgroup preference of TMEM16F on the plasma membrane.. Proc Natl Acad Sci U S A 122(44):e2516822122 PMID: 41166415
- 6. Prescher M et al.. 2021. Evidence for a credit-card-swipe mechanism in the human PC floppase ABCB4.. Structure 29(10):1144-1155.e5 PMID: 34107287
- 7. Clarke RJ et al.. 2020. Physiological roles of transverse lipid asymmetry of animal membranes.. Biochim Biophys Acta Biomembr 1862(10):183382 PMID: 32511979
- 8. Andress EJ et al.. 2017. ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.. Cell Mol Life Sci 74(13):2513-2524 PMID: 28220208
